EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

SLC52A2-Related Riboflavin Transporter Deficiency in Non-Isolated Auditory Neuropathy: Evidence from a Chinese Cohort and a Global Variant Review

Li Wang iD, Jin Li, Wenjing Wang, Mengtao Song, Yi Luo iD, Hongyang Wang iD, Qiuju Wang

Genes · 2026

DOI: 10.3390/genes17101260 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genes, 2026. Verfasst von Li Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Nankai University, Tianjin 300071, China. Hauptthemen laut MEDLINE: Hearing Loss, Central, Membrane Transport Proteins, Receptors, G-Protein-Coupled. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: China National Center for Biotechnology Development, National Natural Science Foundation of China, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Riboflavin transporter deficiency type 2 (RTD2), caused by biallelic pathogenic variants in SLC52A2, is a treatable neurodegenerative disorder in which auditory neuropathy may be an early manifestation. This study characterized the clinical and genetic spectrum of SLC52A2-related RTD2, with emphasis on auditory findings and geographic variation in the reported variant spectrum.

Methods

We screened unrelated probands with clinically diagnosed auditory neuropathy from a multicenter cohort for SLC52A2-related disease. Clinical, audiological, genetic, treatment, and follow-up data were reviewed. PubMed, Web of Science, and Embase were searched from inception through Feb 2026 to summarize reported SLC52A2 variants.

Results

Four patients carried eight distinct SLC52A2 variants, four of which were previously unreported. Audiological testing identified an auditory neuropathy phenotype, with onset between 0.5 and 4 years of age and severity ranging from mild or moderate to profound. In two patients, hearing loss was the first or a concurrent initial manifestation. Riboflavin treatment improved anemia, ataxia, muscle strength, and motor function, whereas established auditory and visual impairment showed limited recovery. The Chinese cohort showed a dispersed variant distribution across SLC52A2, without clustering at known hotspots. In the global dataset, p.G306R was the most frequent variant, accounting for 41.6% (74/178) of reported variant alleles.

Conclusions

SLC52A2-related RTD2 should be considered in children with early-onset or progressive auditory neuropathy and multisystem manifestations. Early molecular diagnosis may permit timely riboflavin treatment before irreversible neural injury develops. The four previously unreported variants expand the SLC52A2 variant spectrum, while the geographic patterns identified in published cases require validation in larger cohorts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hearing Loss, CentralMembrane Transport ProteinsReceptors, G-Protein-CoupledChildChild, PreschoolFemaleHumansInfantMaleChinaCohort StudiesMutationPhenotypeRiboflavinEast Asian People

Stichwörter der Autor:innen

SLC52A2auditory neuropathygenotype–phenotype correlationriboflavinriboflavin transporter deficiency type 2variant spectrum

Substanzen

Membrane Transport ProteinsReceptors, G-Protein-CoupledRiboflavinSLC52A2 protein, human

Autor:innen und Institutionen

  • School of Medicine, Nankai University, Tianjin 300071, China.
  • Senior Department of Otolaryngology Head and Neck Surgery, The 6th Medical Center of Chinese PLA General Hospital, Chinese PLA Medical School, Beijing 100853, China.
  • State Key Laboratory of Hearing and Balance Science, Beijing 100853, China.

ORCID-Profile: Li Wang, Yi Luo, Hongyang Wang

Förderung

  • China National Center for Biotechnology Development
  • National Natural Science Foundation of China
  • National Key Research and Development Program of China

Zitieren

APA

Wang, L., Li, J., Wang, W., Song, M., Luo, Y., Wang, H., & Wang, Q. (2026). SLC52A2-Related Riboflavin Transporter Deficiency in Non-Isolated Auditory Neuropathy: Evidence from a Chinese Cohort and a Global Variant Review. Genes. https://doi.org/10.3390/genes17101260

Vancouver

Wang L, Li J, Wang W, Song M, Luo Y, Wang H, et al. SLC52A2-Related Riboflavin Transporter Deficiency in Non-Isolated Auditory Neuropathy: Evidence from a Chinese Cohort and a Global Variant Review. Genes. 2026. doi:10.3390/genes17101260

BibTeX
@article{Wang2026,
  author = {Wang, Li and Li, Jin and Wang, Wenjing and Song, Mengtao and Luo, Yi and Wang, Hongyang and Wang, Qiuju},
  title = {SLC52A2-Related Riboflavin Transporter Deficiency in Non-Isolated Auditory Neuropathy: Evidence from a Chinese Cohort and a Global Variant Review},
  journal = {Genes},
  year = {2026},
  doi = {10.3390/genes17101260}
}
Kostenlos starten →